Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
06/01/2005 | CN1621409A Novel growth related genes from swine |
06/01/2005 | CN1203847C Chemically-defined non-polymeric valency plateform molecules and conjugates thereof |
05/31/2005 | US6900371 Pesticidal proteins |
05/31/2005 | US6900307 Phenylsulfide derivatives with purine nucleic base containing amine or acyl substituent at 2-position of purine ring |
05/31/2005 | US6900301 Oligonucleotides for use in human therapeutics an diagnostics |
05/31/2005 | US6900299 Antisense oligonucleotide inhalant for prevention and treatment of respiratory system disorders; viricides |
05/31/2005 | US6900297 A compound which hybridizes with a nucleic acid includes multiple inked nucleosides (inlcudes a pentofuranosyl sugar portion and a base portion), and at least one sugar o-is terminated with R-N(R1a R1b) substitutent |
05/31/2005 | US6900187 TRPM-2 antisense therapy using an oligonucleotide having 2′-O-(2-methoxy)ethyl modifications |
05/31/2005 | US6900048 Biopolymer arrays and their fabrication |
05/31/2005 | US6900038 eNOS mutations useful for gene therapy and therapeutic screening |
05/31/2005 | US6900016 Polymorphisms in known genes associated with inflammatory autoimmune disease, methods of detection and uses thereof |
05/31/2005 | US6900013 Methods and compositions for identifying nucleic acid molecules using nucleolytic activities and hybridization |
05/31/2005 | US6899881 H. PYLORI FlbA POLYPEPTIDES, IMMUNOGENIC AND VACCINATING COMPOSITIONS COMPRISING H. PYLORI FlbA POLYPEPTIDES, AND COMPOSITIONS FOR DETECTION OF AN INFECTION COMPRISING H. PYLORI FlbA POLYPEPTIDES |
05/26/2005 | WO2005047850A2 Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins |
05/26/2005 | WO2005047523A2 Short cycle methods for sequencing polynucleotides |
05/26/2005 | WO2005047522A2 Oligonucleotides and methods for detection of west nile virus |
05/26/2005 | WO2005047512A2 Plasmid system for multigene expression |
05/26/2005 | WO2005047511A2 Bacterial expression of protease inhibitors and variants thereof |
05/26/2005 | WO2005047506A1 Rna amidates and thioamidates for rnai |
05/26/2005 | WO2005047505A2 Methods and products for expression of micro rnas |
05/26/2005 | WO2005047501A1 Molecular vaccines employing nucleic acid encoding anti-apoptotic proteins |
05/26/2005 | WO2005047499A1 Polypeptides having beta-glucosidase activity and polynucleotides encoding same |
05/26/2005 | WO2005047481A2 Novel sequences encoding hapatitis c virus glycoproteins |
05/26/2005 | WO2005047480A2 Delta-15 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous plants and yeast |
05/26/2005 | WO2005047479A2 Delta-15 desaturases suitable for altering levels of polyunsaturated fatty acids in oilseed plants and oleaginous yeast |
05/26/2005 | WO2005047471A2 Improved fret efficiency methods |
05/26/2005 | WO2005047470A2 Intercalator fret donors or acceptors |
05/26/2005 | WO2005047469A2 PORCINE ISOGLOBOSIDE 3 SYNTHASE PROTEIN, cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION |
05/26/2005 | WO2005047462A2 Universal control for nucleic acid amplification |
05/26/2005 | WO2005047461A2 Polypeptide display libraries and methods of making and using thereof |
05/26/2005 | WO2005047460A2 Long-wavelength fps |
05/26/2005 | WO2005047459A2 Sars nucleic acids, proteins, antibodies, and uses thereof |
05/26/2005 | WO2005047320A2 Equine p-selection glycoprotein ligand-1 and uses thereof |
05/26/2005 | WO2005047314A2 Fgf-beta binding and supported peptides |
05/26/2005 | WO2005047302A1 Expression in filamentous fungi of protease inhibitors and variants thereof |
05/26/2005 | WO2005047301A1 Improvements in or relating to polynucleotide arrays |
05/26/2005 | WO2005047245A2 Fluorescence assays with improved blocking groups |
05/26/2005 | WO2005046731A1 Interference with c-maf function in multiple myeloma |
05/26/2005 | WO2005046710A2 Tgf-beta binding and supported peptides |
05/26/2005 | WO2005046709A2 Tgf - beta binding and supported peptides |
05/26/2005 | WO2005046708A1 Selective inhibitors of nuclear factor-kb activation and uses thereof |
05/26/2005 | WO2005046622A2 Custom vectors for treating and preventing pancreatic cancer |
05/26/2005 | WO2005046606A2 Compositions and methods for diagnosing and treating chronic lymphocytic leukemia |
05/26/2005 | WO2005046583A2 Modified fviii having reduced immunogenicity through mutagenesis of a2 and c2 epitopes |
05/26/2005 | WO2005046565A2 Diagnosis and treatment of kidney fibrosis and other fibrotic diseases |
05/26/2005 | WO2005046564A2 Diagnosis and treatment of liver fibrosis |
05/26/2005 | WO2005046459A2 Primers, methods and kits for detecting killer-cell immunoglobulin-like receptor alleles |
05/26/2005 | WO2005046309A2 Tomatoes having reduced polygalacturonase activity caused by non-transgenic mutations in the polygalacturonase gene |
05/26/2005 | WO2005009363A3 Treatment of pre-cancerous conditions and prevention of cancer using pcdgf-based therapies |
05/26/2005 | WO2005009217A3 Diagnosis of pre-cancerous conditions using pcdgf agents |
05/26/2005 | WO2004097039A3 Biosynthetic platform for cardioprotective gene expression using neonatal immature and fetal heart tissue |
05/26/2005 | WO2004096826A3 Method for selective inhibition of human n-myc gene in n-myc expressing tumors through antisense and antigen peptido-nucleic acids (pna) |
05/26/2005 | WO2004073604A3 Dna vaccines that express an adp-ribosyltransferase toxin devoid of adp-ribosyltransferase activity |
05/26/2005 | WO2004070008A3 Methods and compositions for using suramin, pentosan polysulfate, telomerase antisense, and telomerase inhibitors |
05/26/2005 | WO2004061126A3 Nucleic acid hybridization assay using bridging sequence |
05/26/2005 | WO2004056312A3 Immunoglobulin variants and uses thereof |
05/26/2005 | WO2004044217A3 Dna sequences from tcd genomic region of photorhabdus luminescens |
05/26/2005 | US20050113569 Preparing an oligonucleotide; coupling a nucleoside to a support-bound nucleotide having a 5'-hydroxyl group, a nucleoside having a 5'-hydroxy protecting group and a 3'-functional group capable of linking to the 5'-hydroxyl group; removing the protecting group in the presence of dichloroacetic acid |
05/26/2005 | US20050113568 Microarrays; animal husbandry; derived from Kagoshima Berkshire |
05/26/2005 | US20050113564 Chimeric receptors with 4-1BB stimulatory signaling domain |
05/26/2005 | US20050113326 Gene expression inhibition; connective tissue growth factor modulators; nucleosides, phosphorothioate/phosphodiester linkages; metabolic diseases, diabetes |
05/26/2005 | US20050113325 Linked/conjugated to lipid, fatty acid, and/or sterol; for inhibiting cancer cell proliferation |
05/26/2005 | US20050113298 Receptor binding peptides derived from the SARS S protein |
05/26/2005 | US20050112751 Novel class of therapeutic protein based molecules |
05/26/2005 | US20050112726 Biosynthetic gene cluster for leptomycins |
05/26/2005 | US20050112725 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/26/2005 | US20050112723 Mammalian cell lines specifically deficient in O-linked glycosylation |
05/26/2005 | US20050112679 Use of ionic liquids for fabrication of polynucleotide arrays |
05/26/2005 | US20050112676 Solid support comprising a plurality of immobilized, positionally distinguishable, multi-subunit sequence specific reagents for use in characterization and classification of biological samples; immunoaffinity chromatography |
05/26/2005 | US20050112673 Fluorescence quenching azo dyes, their methods of preparation and use |
05/26/2005 | US20050112671 Analyzing polymers; such as Dna, Rna; generating signals; using probe capable of hybridization |
05/26/2005 | US20050112667 Microscope system and methods for intracellular studies |
05/26/2005 | US20050112660 Nucleotide sequence coding membrane protein; diagnosis, therapy of nervous system, psychological, brain disorders |
05/26/2005 | US20050112658 Using adsorptive porous membrane |
05/26/2005 | US20050112656 Method for isolating and purifying nucleic acid, cartridge for isolating and purifying nucleic acid, and kit isolating and purifying nucleic acid |
05/26/2005 | US20050112642 Fibroblast growth factor receptors and methods for their use |
05/26/2005 | US20050112636 Detect sensitivity; multiple neotide sequences |
05/26/2005 | US20050112632 Drug resistance to betal blockers; genotyping; transgenic rodents; detecting therapy |
05/26/2005 | US20050112616 Multilayer; immobilized on edges polymer brushes; isolation, separation, transfection; anticancer agents; viricides; bactericides |
05/26/2005 | US20050112613 Sensitivty of infant to shortness ; analyzing Dna in genomes |
05/26/2005 | US20050112612 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore |
05/26/2005 | US20050112604 Diagnosis, monitoring cancer |
05/26/2005 | US20050112595 Analyzig nucleotide sequences; detection restriction fragment length polymorphism; forensics; heredity testing |
05/26/2005 | US20050112592 Assay for species sources |
05/26/2005 | US20050112580 Bacillus stearothermophilus tau, delta, and delta prime polymerase subunits and use thereof |
05/26/2005 | US20050112578 Hybridization of oligonucleotides; three-dimensional; receptivity terminals |
05/26/2005 | US20050112565 Proteases |
05/26/2005 | US20050112563 Sub-sequences of 2'-deoxy-erythro-pentofuranosyl nucleotides that activate RNase H enzyme; diagnostics; antisense therapeutics |
05/26/2005 | US20050112561 Compositions and kits for herpes simplex virus type 1 and 2 nucleic acid detection |
05/26/2005 | US20050112558 SARS-specific probes to the SARS-specific nucleic acid; quantitative assessment of the SARS-CoV viral titer found in a biological specimen from a patient |
05/26/2005 | US20050112237 food additive with a PS4 variant polypeptide derivable from a parent polypeptide having non-maltogenic exoamylase activity; baked goods; glucan 1,4-alpha-maltotetrahydrolase activity |
05/26/2005 | US20050112134 Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease |
05/26/2005 | US20050112119 Antibodies which bind human CXCR3 |
05/26/2005 | US20050112102 Viral proteins which stimulating immunology response |
05/26/2005 | CA2793127A1 Oligonucleotides and methods for detection of west nile virus |
05/26/2005 | CA2548080A1 Porcine isogloboside 3 synthase protein, cdna, genomic organization, and regulatory region |
05/26/2005 | CA2545807A1 Oligonucleotides and methods for detection of west nile virus |
05/26/2005 | CA2545755A1 Plasmid system for multigene expression |
05/26/2005 | CA2545619A1 Short cycle methods for sequencing polynucleotides |
05/26/2005 | CA2545252A1 Improved methods for detecting and measuring specific nucleic acid sequences |